Ironwood Pharmaceuticals | Frais De Vente Et D'Administration



Selling And Administration Expenses Changement Date
Acadia Pharmaceuticals USD 130.08M 3.21M 2024-12
Agios Pharmaceuticals USD 51.7M 13.16M 2024-12
Almirall EUR -50222000 162.22M 2024-06
Alnylam Pharmaceuticals USD 295.34M 74.35M 2024-12
Amarin USD 36.9M 1.64M 2024-09
Ardelyx USD 76.07M 11.1M 2024-12
Astellas Pharma JPY 211.32B 13.99B 2025-03
AstraZeneca USD 5.55B 307M 2024-12
Charles River Laboratories USD 188.26M 946K 2024-12
Exact Sciences USD 370.43M 41.42M 2024-12
Halozyme Therapeutics USD 42.25M 1.01M 2024-12
Incyte USD 326.71M 17.5M 2024-12
Ironwood Pharmaceuticals USD 33.33M 2.78M 2024-12
MacroGenics USD 27.81M 13.71M 2024-12
Moderna USD 351M 70M 2024-12
Myriad Genetics USD 136M 3.1M 2024-12
Pacira USD 79.61M 5.28M 2024-12
PTC Therapeutics USD 84.68M 11.23M 2024-12
Sarepta Therapeutics USD 163.87M 35.67M 2024-12
Takeda JPY 270.59B 2.31B 2024-12
Ultragenyx Pharmaceutical USD 82.49M 2.14M 2024-12



Ironwood Pharmaceuticals Frais De Vente Et D'Administration - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Apr 2025.